ASSEMBLY BIOSCIENCES, INC. - Common Stock, par value $0.001 (ASMB)

Historical Holders from Q3 2014 to Q1 2024

Symbol
ASMB on Nasdaq
CUSIP
045396108
Type / Class
Equity / Common Stock, par value $0.001
Shares outstanding
15.5M
All holders as of March 31, 2024
Q1 2024
Total 13F shares, excl. options
0
Holdings value
$0
Number of holders
0
Number of sells
-41
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of ASSEMBLY BIOSCIENCES, INC. - Common Stock, par value $0.001 (ASMB)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
GILEAD SCIENCES, INC. 29% -3% 4.51M +104% GILEAD SCIENCES, INC. Aug 8, 2025

Institutional Holders of ASSEMBLY BIOSCIENCES, INC. - Common Stock, par value $0.001 (ASMB)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 0 $0 -$7.09M 0
2023 Q4 8.65M $7.09M -$888K $0.82 42
2023 Q3 9.54M $8.44M -$823K $0.89 32
2023 Q2 10.5M $12M -$1.41M $1.15 31
2023 Q1 12.1M $10.1M -$2.7M $0.84 37
2022 Q4 14.2M $18.4M -$3.48M $1.30 38
2022 Q3 16.6M $27.2M -$1.06M $1.64 47
2022 Q2 17.2M $36.1M -$3.86M $2.10 51
2022 Q1 19.1M $39.3M -$9M $2.06 52
2021 Q4 23.1M $53.8M -$9.79M $2.33 57
2021 Q3 22.7M $79M -$15.5M $3.48 61
2021 Q2 27.1M $105M -$6.95M $3.88 88
2021 Q1 27.2M $125M +$3.46M $4.60 102
2020 Q4 26.7M $161M -$149M $6.05 107
2020 Q3 30.1M $495M +$966K $16.44 115
2020 Q2 30M $700M +$25.4M $23.32 104
2020 Q1 29M $430M +$7.11M $14.83 97
2019 Q4 28.1M $576M +$162M $20.46 101
2019 Q3 20.7M $204M -$9.08M $9.83 96
2019 Q2 21.1M $286M -$38.4M $13.49 106
2019 Q1 22.1M $435M +$11.6M $19.69 102
2018 Q4 21.3M $483M -$22.4M $22.62 105
2018 Q3 21.5M $797M +$178M $37.14 111
2018 Q2 16.6M $652M +$19.1M $39.21 103
2018 Q1 16.1M $789M +$27.4M $49.14 106
2017 Q4 15.6M $704M +$144M $45.25 97
2017 Q3 12.4M $431M -$9.93M $34.92 71
2017 Q2 12.5M $259M +$12.7M $20.65 65
2017 Q1 11.9M $301M +$19.7M $25.49 49
2016 Q4 11.7M $140M +$7.38M $12.15 36
2016 Q3 11.1M $79.4M -$992K $7.21 35
2016 Q2 11.3M $61.9M -$5.13M $5.55 42
2016 Q1 12.4M $61.6M -$832K $5.02 45
2015 Q4 12.3M $92.3M -$1.08M $7.51 48
2015 Q3 12.4M $118M -$281K $9.56 50
2015 Q2 12.1M $232M +$27.4M $19.26 57
2015 Q1 10.8M $142M +$85.1M $13.24 32
2014 Q4 4.3M $33.5M +$11M $7.86 22
2014 Q3 1.64M $13.4M +$13.4M $8.19 20